Medications for Hodgkin Disease

3 results
  • adcetris - brentuximab vedotin injection, powder, lyophilized, for solution

    (Brentuximab Vedotin)
    Seagen Inc.
    ADCETRIS treats classical Hodgkin lymphoma (untreated, consolidation, or relapsed), systemic and cutaneous anaplastic large cell lymphoma, CD30-expressing mycosis fungoides, peripheral T-cell lymphomas, and relapsed/refractory large B-cell lymphoma in adults; and high-risk cHL in pediatric patients 2 years and older.
  • leukine - sargramostim injection, powder, lyophilized, for solution

    (Sargramostim)
    Partner Therapeutics, Inc.
    Leukine is a leukocyte growth factor used to shorten neutrophil recovery after AML chemotherapy in adults 55+, mobilize stem cells for transplant, accelerate myeloid reconstitution after bone marrow or progenitor cell transplantation, treat delayed neutrophil recovery or graft failure, and increase survival after myelosuppressive radiation exposure.
  • opdivo - nivolumab injection

    (Nivolumab)
    E.R. Squibb & Sons, L.L.C.
    Opdivo is a PD-1 blocking antibody indicated for multiple cancers including melanoma, non-small cell lung cancer, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, colorectal cancer, hepatocellular carcinoma, esophageal cancer, and gastric cancers in adults and select pediatric patients.